EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte Studie

Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%

Zoe D Draelos, Kizito Kyeremateng, Nicholas Squittieri

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.8774 ↗

At a glance

Randomisierte kontrollierte Studie in Journal of Drugs in Dermatology, 2025. Written by Zoe D Draelos and 2 co-authors. Major MEDLINE topics: Skin Cream, Acne Vulgaris, Water Loss, Insensible, Cortodoxone. Cited 1 times so far (Crossref).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: Topical medications commonly prescribed for the treatment of acne vulgaris may be limited by application-site dryness, which can result in skin barrier damage. This study aimed to evaluate the effects of clascoterone cream 1% on skin barrier properties in acne-prone individuals. METHODS: Participants ≥18 years of age with acne-prone skin were enrolled in a single-center, split-face study and randomized to twice-daily treatment with clascoterone cream 1% (approximately 0.5 g) to the right or left side of the face for 2 weeks. The primary and secondary endpoints were the changes in corneometry reading and transepidermal water loss (TEWL), respectively, between treated and untreated sides at week 2. Tolerability was evaluated from the severity of dryness, erythema, scaling, irritation, tightness, stinging, itching, and burning for each side using a 5-point scale from 0 (none) to 4 (severe). RESULTS: This study enrolled 50 participants (female, n = 38) with a mean ± standard deviation (SD) age of 31.1 ± 8.9 years. The mean ± SD corneometry reading was significantly higher for the treated vs untreated side at week 2 (131.3 ± 42.9 vs 113.9 ± 36.6; P

Subjects

MeSH terms (MEDLINE)

Skin CreamAcne VulgarisWater Loss, InsensibleCortodoxoneDermatologic AgentsHumansFemaleMaleAdultAdministration, CutaneousYoung AdultSkinTreatment OutcomeAdolescentPropionates

Substances

ClascoteroneCortodoxoneDermatologic AgentsPropionates

Cite

APA

D Draelos, Z., Kyeremateng, K., & Squittieri, N. (2025). Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8774

Vancouver

D Draelos Z, Kyeremateng K, Squittieri N. Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.8774

BibTeX
@article{DDraelos2025,
  author = {D Draelos, Zoe and Kyeremateng, Kizito and Squittieri, Nicholas},
  title = {Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.8774}
}
Start for free →